scispace - formally typeset
Open AccessJournal ArticleDOI

Clinical Study of Mesenchymal Stem Cell Treatment for Acute Respiratory Distress Syndrome Induced by Epidemic Influenza A (H7N9) Infection: A Hint for COVID-19 Treatment

TLDR
It is suggested that MSCs significantly improve the survival rate of H7N9-induced ARDS and provide a theoretical basis for the treatment of H6N9 and the corona virus disease 2019 (COVID-19) in both preclinical research and clinical studies.
About
This article is published in Engineering.The article was published on 2020-02-28 and is currently open access. It has received 218 citations till now. The article focuses on the topics: ARDS & Transplantation.

read more

Citations
More filters
Journal ArticleDOI

The cytokine storm and COVID-19.

TL;DR: The current understanding of the features of SARS‐CoV‐2 and the pathological features, pathophysiological mechanisms, and treatments of the cytokine storm induced by COVID‐19 are reviewed and it is suggested that the identification and treatment of theocyte storm are important components for rescuing patients with severe CO VID‐19.
Journal ArticleDOI

COVID-19: immunopathogenesis and Immunotherapeutics.

TL;DR: The immunopathology of COVID-19 is discussed, its potential mechanisms, and clinical implications to aid the development of new therapeutic strategies against COIDs, which includes enhancing anti-viral immunity while inhibiting systemic inflammation.
Journal ArticleDOI

Mesenchymal Stem Cell Therapy for COVID-19: Present or Future.

TL;DR: This study considered this new approach to improve patient’s immunological responses to COVID-19 using MSCs and discussed the aspects of this proposed treatment.
Journal ArticleDOI

COVID-19 vaccines: The status and perspectives in delivery points of view.

TL;DR: In this paper, the virology and immunology of SARS-CoV-2, alternative therapies for COVID-19 to vaccination, principles and design considerations in vaccine development, and the promises and roles of vaccine carriers in addressing the unique immunopathological challenges presented by the disease.
References
More filters
Journal ArticleDOI

A Novel Coronavirus from Patients with Pneumonia in China, 2019.

TL;DR: Human airway epithelial cells were used to isolate a novel coronavirus, named 2019-nCoV, which formed a clade within the subgenus sarbecovirus, Orthocoronavirinae subfamily, which is the seventh member of the family of coronaviruses that infect humans.
Related Papers (5)